Creative Planning’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.08M Sell
15,580
-519
-3% -$169K ﹤0.01% 749
2025
Q1
$4.35M Buy
16,099
+5,286
+49% +$1.43M ﹤0.01% 762
2024
Q4
$2.54M Buy
10,813
+801
+8% +$188K ﹤0.01% 986
2024
Q3
$2.75M Buy
10,012
+1,978
+25% +$544K ﹤0.01% 905
2024
Q2
$1.95M Buy
8,034
+3,110
+63% +$756K ﹤0.01% 994
2024
Q1
$736K Sell
4,924
-148
-3% -$22.1K ﹤0.01% 1565
2023
Q4
$971K Buy
5,072
+951
+23% +$182K ﹤0.01% 1241
2023
Q3
$730K Sell
4,121
-835
-17% -$148K ﹤0.01% 1318
2023
Q2
$941K Buy
4,956
+1,379
+39% +$262K ﹤0.01% 1152
2023
Q1
$717K Buy
3,577
+314
+10% +$62.9K ﹤0.01% 1256
2022
Q4
$775K Buy
3,263
+676
+26% +$161K ﹤0.01% 1159
2022
Q3
$518K Buy
2,587
+62
+2% +$12.4K ﹤0.01% 1308
2022
Q2
$368K Buy
2,525
+1,146
+83% +$167K ﹤0.01% 1469
2022
Q1
$225K Sell
1,379
-337
-20% -$55K ﹤0.01% 1817
2021
Q4
$291K Buy
1,716
+248
+17% +$42.1K ﹤0.01% 1639
2021
Q3
$277K Buy
+1,468
New +$277K ﹤0.01% 1639
2019
Q3
Sell
-21,194
Closed -$1.54M 1871
2019
Q2
$1.54M Buy
+21,194
New +$1.54M 0.01% 579
2017
Q3
Sell
-1,045
Closed -$83K 1910
2017
Q2
$83K Buy
1,045
+38
+4% +$3.02K ﹤0.01% 2110
2017
Q1
$52K Buy
1,007
+300
+42% +$15.5K ﹤0.01% 2421
2016
Q4
$26K Buy
707
+95
+16% +$3.49K ﹤0.01% 2849
2016
Q3
$41K Buy
612
+542
+774% +$36.3K ﹤0.01% 2493
2016
Q2
$4K Hold
70
﹤0.01% 3647
2016
Q1
$4K Sell
70
-600
-90% -$34.3K ﹤0.01% 3611
2015
Q4
$63K Hold
670
﹤0.01% 1904
2015
Q3
$54K Buy
+670
New +$54K ﹤0.01% 1972
2015
Q2
Sell
-70
Closed -$7K 1121
2015
Q1
$7K Buy
+70
New +$7K ﹤0.01% 3321
2014
Q4
Sell
-600
Closed -$47K 3990
2014
Q3
$47K Buy
+600
New +$47K ﹤0.01% 1943